"Suzhou Jiecheng Medical Technology Co., Ltd." is a high-tech medical technology company with completely independent intellectual property rights and its patented technology is in a leading position in the world. The company was established in September 2009. The R&D team consists of Cardiologist Zhang Ji and several domestic and foreign R&D experts. The company's leading project is the development and production of the innovative "J-Valve Precision Positioning Heart Valve Implant System" technology.
"J-Valve Precise Positioning Heart Valve Implant System" is a minimally invasive surgical technique that eliminates the need to open a chest and eliminates extracorporeal blood circulation. It can significantly reduce patient's surgical trauma, shorten postoperative recovery time, reduce patient's pain, and reduce The requirements of the patient's physical condition, thereby expanding the range of application of the disease, improving the efficacy of treatment, reducing the cost of surgery, so that the majority of patients need to replace the heart valve can be treated. Other similar products can only be implanted into the heart through the use of imaging technology. The J-Valve system can completely rely on its own positioning device to assist doctors in performing valve replacement surgery, thereby reducing the risk of surgery, easier to operate and master, and simplifying the heart valve Replacement process. The above advantages will help reduce the overall cost of the country's health care system, promote the reform of the health care system, reduce medical costs, and save social medical resources. At the same time, drastic changes in the long-term dependence on imported heart valves will help China's minimally invasive medical technology to lead the world.
The J-Valve system has received a number of awards including the China Medical Device Technology Innovation Award from the China Medical Device Industry Association. Dr. Zhang Ji, the inventor of the technology, is an emeritus professor in the Department of Cardiovascular Surgery at the Department of Medicine of Peking University.
At present, the J-Valve system has received extensive attention from the medical community at home and abroad. At the same time, the US FDA is also very concerned about this technology and is willing to promote clinical trials in the United States. The J-Valve system was approved by the State Food and Drug Administration in April 2017 after clinical trials. As of January 2018, the product has helped treat more than 200 heart valve patients. In addition, the product was approved by the Canadian Ministry of Health for special access. At St. Paul's Hospital, the largest cardiac surgery hospital in Vancouver, minimally invasive heart valve replacement was performed successfully for a dozen Canadian patients with severe aortic insufficiency. The core technological advantage and rich experience will ensure that this technology will maintain its leading position in the market. Liu Fei, the Chinese consul general in Vancouver, said that in terms of science and technology, China had previously imported high-tech products and technology from Canada, and the J-Valve system was the first high-tech medical device in developed countries that used all of China’s intellectual property rights. A broad area means that China's creation in the field of medical devices is going global. National science and technology authorities believe that this invention is of great significance to the heart of the world. We believe that the company's development prospects are very broad. At the same time, we will strive to turn our company into a world-class cardiovascular and medical device company in China and even the world. The vision of Suzhou Jiecheng Medical Technology Co., Ltd. is to help doctors and save patients (Partnering with physician, saving life). The purpose is: to create cardiovascular medical equipment for the benefit of mankind.
+86-512-63179788(WJ) | +86-512-63036288(SZ)
Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China
C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China